List view / Grid view
19 August 2015 | By Victoria White
Scientists have developed a potentially better and more accurate high-throughput screening technique and have used it to identify 24 drug candidates...
19 August 2015 | By Victoria White
Roche has signed a definitive agreement to acquire Kapa Biosystems, strengthening Roche's next-generation sequencing product offerings...
19 August 2015 | By Victoria White
AmpliPhi Biosciences Corporation has announced that its shares of common stock have been approved for listing on the NYSE MKT...
18 August 2015 | By Victoria White
Cancer Research UK will fund preclinical research evaluating the efficacy of Imprime PGG in combination with monoclonal antibody (MAb) therapies...
18 August 2015 | By The European Antibody Congress
The European Antibody Congress takes place 9-11 November 2015 at the Congress Centre, Basel...
18 August 2015 | By Victoria White
Researchers have discovered a small molecule, known as CLR01, that attacks the HIV virus and disrupts the amyloids in semen that promote HIV infection...
18 August 2015 | By Victoria White
Testing for genetic risk factors could improve treatment for myeloma patients by identifying those at risk of developing more aggressive disease...
17 August 2015 | By Victoria White
Scientists have created a liver-on-chip device mimicking human physiology, leading to the discovery of a new mechanism of paracetamol toxicity...
17 August 2015 | By Victoria White
Genetically altered mice could form the basis for research into new treatments for cognitive disorders such as Alzheimer’s disease and schizophrenia...
17 August 2015 | By Victoria White
Researchers from have identified the molecular mechanism that an adhesion protein of H. pylori uses to attach to stomach ulcers...
17 August 2015 | By Victoria White
Researchers have developed an experimental, nanoparticle-based vaccine against Epstein-Barr virus that can induce potent neutralising antibodies in animals...
17 August 2015 | By Victoria White
Researchers supported by the NIH have discovered a type of cell, known as hybrid hepatocytes, essential to regeneration of the liver...
14 August 2015 | By Katie Sadler, Digital Content Producer, Drug Target Review
Biotechnology company, AmpliPhi Biosciences Corporation, released financial results for the second quarter 2015 and operational highlights. AmpliPhi, one of the leaders in the development of bacteriophage-based antibacterial therapies to treat antibiotic-resistant infections, has reported strong overall performance in overall liquidity and balance sheet strength thanks to a $13 million investment…
12 August 2015 | By Author: Katie Sadler, Digital Content Producer, Drug Target Review
Research carried out by University of California San Francisco (UCSF) has revealed ion channel blocking drugs could play a part in cancer therapy. The common class of channel blocking drugs, which are used to treat cardiac, neurological, and psychiatric disorders, could prove to be beneficial in cancer treatment according to…
11 August 2015 | By Katie Sadler, Digital Content Producer, Drug Target Review
Johns Hopkins researchers have identified a novel cell signalling pathway in mice through which mammals can regenerate hair and skin while healing from wounds. The discovery, summarised in an article published on 6th August in the journal Cell Stem Cell, could, they say, eventually help spur the growth of new…
